CH-01 is a Hypoxia-Activated Prodrug That Sensitizes Cells to Hypoxia/Reoxygenation Through Inhibition of Chk1 and Aurora A
Main Authors: | Cazares-Körner, Cindy, Pires, Isabel M., Swallow, I. Diane, Grayer, Samuel C., O’Connor, Liam J., Olcina, Monica M., Christlieb, Martin, Conway, Stuart J., Hammond, Ester M. |
---|---|
Format: | Online |
Language: | English |
Published: |
American
Chemical Society
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719478/ |
Similar Items
-
ATM activation in hypoxia - causes and consequences
by: Olcina, Monica M, et al.
Published: (2014) -
Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition
by: Meng, Fanying, et al.
Published: (2015) -
Editorial – Hypoxia and Reoxygenation: From Basic Science to Bedside
by: Samaja, Michele, et al.
Published: (2015) -
Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
by: Guise, Christopher P., et al.
Published: (2014) -
Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species☆
by: Kolamunne, Rajitha T, et al.
Published: (2013)